Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04635995
Status:
RECRUITING
Last Update Posted:
2023-06-23
First Post:
2020-11-09
Brief Title:
Phase 1 Trial of LVGN7409 CD40 Agonist Antibody as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Sponsor:
Lyvgen Biopharma Holdings Limited
Organization:
Lyvgen Biopharma Holdings Limited
Organization Data
Organization:
Lyvgen Biopharma Holdings Limited
Class:
INDUSTRY
Study ID:
LVGN7409-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lyvgen Biopharma Holdings Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None